| Gary Czulada, DO | |
|
3740 Carlisle Rd, Dover, PA 17315-4416 | |
| (717) 292-3168 | |
| (717) 292-3479 |
| Full Name | Gary Czulada |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 39 Years |
| Location | 3740 Carlisle Rd, Dover, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477578573 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS005842L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aseracare Hospice | York, PA | Hospice |
| York Hospital | York, PA | Hospital |
| Upmc Memorial | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Davenshire Medical Center Partnership | 2062400187 | 3 |
News Archive
In recent years, the number of women who entered U.S. medical school surpassed the number of men. But gender inequities still exist in many areas of medicine.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for verification and validation studies on a new potency test for influenza viruses with pandemic potential.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
› Verified 6 days ago
| Entity Name | Davenshire Medical Center Partnership |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023040490 PECOS PAC ID: 2062400187 Enrollment ID: O20040505001237 |
News Archive
In recent years, the number of women who entered U.S. medical school surpassed the number of men. But gender inequities still exist in many areas of medicine.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for verification and validation studies on a new potency test for influenza viruses with pandemic potential.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gary Czulada, DO 3740 Carlisle Rd, Dover, PA 17315-4416 Ph: (717) 292-3168 | Gary Czulada, DO 3740 Carlisle Rd, Dover, PA 17315-4416 Ph: (717) 292-3168 |
News Archive
In recent years, the number of women who entered U.S. medical school surpassed the number of men. But gender inequities still exist in many areas of medicine.
Featured in the October edition of the Journal of Thoracic Oncology (JTO), data from The Tarceva Lung Cancer Survival Treatment (TRUST) confirms the safety and efficacy profile of erlotinib, a highly potent oral active, reversible inhibitor of epidermal growth factor receptor (EGFR) tyrosine-kinase (TK) activity in a large heterogeneous non-small cell lung cancer (NSCLC) population.
InDevR, Inc., an innovative life science company dedicated to improving biopharmaceutical and vaccine manufacturing, announced support from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for verification and validation studies on a new potency test for influenza viruses with pandemic potential.
Stem cells extracted from body fat may pave the way for the development of new regenerative therapies including soft tissue reconstruction following tumor removal or breast mastectomy surgery, the development of tissue-engineered cartilage or bone, and the treatment of cardiovascular disease.
› Verified 6 days ago
Karen Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3992 Carlisle Rd, Dover, PA 17315 Phone: 717-292-7494 Fax: 717-292-2398 | |
Melissa Baylor, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3740 Carlisle Rd, Dover, PA 17315 Phone: 717-292-3168 Fax: 717-292-3479 | |
Larry Smith, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3992 Carlisle Rd, Dover, PA 17315 Phone: 717-292-7494 Fax: 717-292-2398 | |
Debra Mason Altland, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3992 Carlisle Rd, Dover, PA 17315 Phone: 717-292-7494 Fax: 717-292-2398 |